Quinoline derivatives as PI3 kinase inhibitors
US8138347B2 · kind B2 · utility
147Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2008 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Jun 19, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.